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Objective: Knowledge about the mechanisms underlying the cytotoxicity of tetrandrine and caffeine on
glioma cells is limited. The primary objective of this study was to assess the expression of mammalian
target of rapamycin (mTOR), phosphatase and tensin homolog (PTEN), histone deacetylase 1 (HDAC1),
and histone acetyltransferase (p300) in RT-2 glioma cells treated with caffeine and/or tetrandrine.
Materials and methods: The cell viability and expression of mTOR, PTEN, HDAC1, and p300 in RT-2 glioma
cells were assayed after treatment with caffeine and/or tetrandrine for 48 hours.
Results: The cell viability of RT-2 cells decreased signiﬁcantly 48 hours after treatment with tetrandrine
(5 mM) alone and tetrandrine (5 mM) combined with caffeine (0.5 mM or 1 mM), but not caffeine (0.5 mM
or 1 mM) alone. The protein levels of mTOR, PTEN, and HDAC1 did not appear to change signiﬁcantly
after treatment with caffeine (0.5 mM or 1 mM) alone, tetrandrine (5 mM) alone, or their combinations.
However, p300 increased signiﬁcantly after treatment with caffeine (0.5 mM or 1 mM) alone, tetrandrine
(5 mM) alone, and their combinations.
Conclusion: Tetrandrine and caffeine can increase glioma cell death additively possibly via increasing
p300 expression.
Copyright © 2015, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC. All
rights reserved.1. Introduction
Malignant glioma is the most common primary brain tumor in
adults. The prognosis of patients with glioblastoma remains very
poor [1], and development of new drugs is urgently needed. The
poor prognosis of malignant glioma is largely attributable to a
highly deregulated tumor genome with opportunistic deletion of
tumor suppressor genes, ampliﬁcation and/or mutational hyper-
activation of receptor tyrosine kinase receptors, and defects in the
apoptosis signaling machinery [2].logy, Dalin Tzu Chi Hospital,
Road, Dalin, Chiayi, Taiwan.
ang).
elief Tzu Chi Foundation. PublisheA previous study showed that phosphatidylinositol 3 kinase
(PI3K)/protein kinase B (Akt) is overexpressed in glioma cells [3].
Mammalian target of rapamycin (mTOR) is a PI3K-related serine/
threonine kinase and can regulate cell proliferation, growth, dif-
ferentiation, and survival [4]. Phosphatase and tensin homolog
(PTEN), as a tumor suppressor gene, can downregulate the PI3K-
mediated cell signaling pathway via acting on Akt. However,
PTEN is often inactivated inmany cancer cells, includingmelanoma,
glioma, and cancers of the breast, prostate, and endometrium [5,6].
Histone deacetylases (HDACs) and histone acetyl transferases
(HATs) are involved in determining the state of acetylation of his-
tones and are early steps in genetic transcription [7]. There are
reports that altered activities of HDACs and HATs are associated
with cancer formation. For example, overexpression of HDAC1 has
been associated with human gastric and prostate cancers, and
malignant glioma [8]. Thus, HDAC1 has recently become recognizedd by Elsevier Taiwan LLC. All rights reserved.
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malignant glioma. The decreased expressions of HATs have also
been associated with several diseases, such as cardiac hypertrophy,
asthma, and cancers [9]. Loss of heterozygosity of HAT p300 was
found in 80% of malignant glioma [10].
Previous studies showed that caffeine and tetrandrine have
antiglioma effects [11e16]. Caffeine can attenuate the G2 delay
produced by cisplatin and camptothecin, and enhance the cyto-
toxicity of cisplatin and camptothecin in human brain tumor cell
lines [16]. Caffeine has been reported to inhibit some kinase ac-
tivities, including various forms of mTOR and PI3K, in tumor cells
[17]. Moreover, caffeine can increase PTEN expression, leading to
PI3KeAKT pathway inactivation, and block osteosarcoma cell pro-
liferation [18]. However, the effects of caffeine on the expression of
HDAC1 and p300 in glioma cells are still unknown. Tetrandrine is a
bis-benzylisoquinoline alkaloid and can increase P38 and mitogen-
activated protein kinase activity, exert antiangiogenesis, and induce
the caspase-dependent cell death pathway [11e13]. However, the
effects of tetrandrine on the expression of mTOR, PTEN, HDAC1, and
p300 in glioma cells are still unknown.
In this experimental study, we aimed to investigate the effects of
caffeine and tetrandrine on cell viability and expression of mTOR,
PTEN, HDAC1, and p300 in malignant glioma cells. We hypothe-
sized that caffeine and tetrandrine could increase the cell death of
RT2 glioma cells additively via decreasing mTOR and HDAC1
expression, and increasing PTEN and p300 expression.
2. Materials and methods
2.1. Cell line
RT-2 cells were derived from an avian sarcoma virus-induced
brain tumor in the Fischer 344 rat. This cell line was provided by
the National Taiwan University Hospital, Taipei, Taiwan [12,13], and
maintained in Dulbecco's modiﬁed Eagle's medium supplemented
with 10% fetal bovine serum, 2 mM L-glutamate, and 100 U/mL
penicillin at 37C in a humidiﬁed incubator with a 5% CO2
atmosphere.
2.2. Cell viability assay
Cell viability was measured at 48 hours after treatment with
various concentrations of caffeine (0mM, 0.5mM,1mM, 2mM, and
5mM) and/or tetrandrine (0 mM, 5 mM, 10 mM, and 15 mM) using a
colorimetric assay for 96-well plates with 2-(4-iodophenyl)-3-(4-
nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium monosodium
salt (WST-1) reagent. Each plate contained blanks, controls, and
treatment groups. Treatment consisted of addition of 10 mL of
Premixed WST-1 Cell Proliferation Reagent (Abcam, USA) to each
well (1:10 ﬁnal dilution).
The plate was incubated for 4 hours at 37C in a humidiﬁed
atmosphere maintained at 5% CO2. The absorbance was measured
at 450 nm (reference wavelength, 690 nm) using a multiwell plate
reader.
2.3. Western blot analysis
Low concentrations of caffeine (0 mM, 0.5 mM, and 1 mM) and/
or tetrandrine (0 mM and 5 mM) were chosen for Western blot
analysis at 48 hours after the cell viability assay. Both adherent and
ﬂoating cells were collected. The cell pellets were resuspended
with radioimmunoprecipitation assay lysis buffer and lysed at 4C
for 30 minutes. After 65,000 g centrifugation for 30 minutes, the
protein content of the supernatant was determined using the
bicinchoninic acid protein assay. Equal amounts of the total proteinwere separated by 10% sodium dodecyl sulfate-polyacrylamide gel
electrophoresis and transferred to nitrocellulose membranes,
which were soaked in blocking buffer (1% bovine serum albumin).
Proteins were detected using polyclonal antibodies against mTOR
and PTEN, and then visualized using goat-antirabbit immuno-
globulin G conjugated with horseradish peroxidase as the horse-
radish peroxidase substrate. The expression levels of mTOR and
PTEN were presented as relative ratios in comparison to b-actin.
2.4. HDAC1 activity assay
Assays were performed using the enzyme-linked immunosor-
bent assay (ELISA) Assay Kit for HDAC1from USCN Life Sciences
(Wuhan, Hubei, China) according to the manufacturer's in-
structions. Brieﬂy, 100 mL of cells, standard, and blank were added
to each well, and incubated for 2 hours at 37C. Next, the liquid
from each well was removed. Detection Reagent A (100 mL) was
added, and the plate was incubated for 1 hour at 37C. This was
followed by aspiration, and the solution was washed three times.
The wells were added with Detection Reagent B (100 mL), then
incubated for 30 minutes at 37C. Aspiration followed, and the
solution was washed ﬁve times. Next, 90 mL Substrate Solution was
added, followed by incubation for 20 minutes at 37C. Then, Stop
Solution (50 mL) was added and ELISA plate reader at 450 nm.
HDAC1 activity was expressed as the relative optical density values
per nanogram of the protein sample.
2.5. HAT (p300) activity assay
Assayswere performed using the HATactivity colorimetric assay
from BioVision (BioVision Research Products, Mountain View, CA,
USA) according to the manufacturer's instructions. Brieﬂy, 50 mg of
puriﬁed proteins from cells were diluted in 40 mL of ddH2O; 68 mL of
Assay Mix was then added, followed by incubation at 37C for 1e4
hours. Samples were then read in an ELISA plate reader at 440 nm.
HAT (p300) activity was expressed as the relative optical density
values per microgram of the protein sample.
2.6. Statistical analysis
The data are presented as the mean ± standard deviation, unless
indicated otherwise. The expression levels of mTOR, PTEN, HDAC1,
and p300 were compared separately between all groups by one-
way analysis of variance (ANOVA) with post-hoc Bonferroni
correction. All analyses were performed using the commercialized
software STATA10, and p < 0.05 was considered statistically
signiﬁcant.
Data are representative of three independent experiments (er-
ror bars, standard deviation of triplicate samples).
3. Results
Fig. 1 shows the effects of various concentrations of caffeine
(0 mM, 0.5 mM, and 1 mM) and/or tetrandrine (0 mM and 5 mM) on
the cell viability of RT2 glioma cells at 48 hours. Compared with the
control group without caffeine or tetrandrine treatment, the cell
viability decreased signiﬁcantly when RT-2 cells were treated with
tetrandrine in various concentrations (5 mM) alone, and combined
with caffeine (0.5 mM or 1 mM; one-way ANOVA, p < 0.0001; post-
hoc Bonferroni correction, p < 0.001 for each concentration).
Compared with tetrandrine treatment (5 mM) alone, the cell
viability decreased signiﬁcantly when RT-2 cells were treated with
combined tetrandrine (5 mM) and caffeine (1mM; one-way ANOVA,
p < 0.0001; post-hoc Bonferroni correction, p < 0.001 for each
concentration).
Fig. 1. Effects of various concentrations of caffeine (0 mM, 0.5 mM, and 1 mM) and/or
tetrandrine (0 mM and 5 mM) on the cell viability of RT2 glioma cells at 48 hours. Cell
viability decreased signiﬁcantly when RT2 cells were treated with tetrandrine (5 mM)
alone, or combinations of tetrandrine (5 mM) and caffeine (0.5 mM or 1 mM).
Fig. 3. Ratio of phosphatase and tensin homolog (PTEN) versus b-actin expressionwith
various concentrations of caffeine (0.5 mM or 1 mM) and/or tetrandrine (5 mM) in RT-2
glioma cells. Expression of PTEN was not signiﬁcantly different in any treatment group
(one-way analysis of variance, p ¼ 0.6961), although PTEN expression tended to in-
crease after treatment with caffeine (0.5 mM or 1 mM) and/or tetrandrine (5 mM).
Fig. 4. Concentration of histone deacetylase 1 (HDAC1) with various concentrations of
caffeine (0.5 mM or 1 mM) and/or tetrandrine (5 mM) in RT-2 glioma cells. Expression
of HDAC1 was not signiﬁcantly different in any treatment group (one-way analysis of
variance, p ¼ 0.1445), although HDAC1 expression tended to decrease after treatment
with caffeine (0.5 mM or 1 mM) and/or tetrandrine (5 mM).
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various concentrations of caffeine (0.5 mM or 1 mM) and/or tet-
randrine (5 mM) in RT-2 glioma cells. The expression of mTOR was
not signiﬁcantly different in any treatment group (one-way
ANOVA, p¼ 0.8981), althoughmTOR expression tended to decrease
under treatment with caffeine (0.5 mM or 1 mM) and/or tetran-
drine (5 mM).
Fig. 3 shows the ratio of PTEN versus b-actin expression with
various concentrations of caffeine (0.5 mM or 1 mM) and/or tet-
randrine (5 mM) in RT-2 glioma cells. The expression of PTEN was
not signiﬁcantly different in any treatment group (one-way
ANOVA, p ¼ 0.6961), although PTEN expression tended to increase
under treatment with caffeine (0.5 mM or 1 mM) and/or tetran-
drine (5 mM).
Fig. 4 shows the concentration of HDAC1 with various concen-
trations of caffeine (0.5 mM or 1 mM) and/or tetrandrine (5 mM) in
RT-2 glioma cells. The expression of HDAC1 was not signiﬁcantly
different in any treatment group (one-way ANOVA, p ¼ 0.1445),
although HDAC1 expression tended to decrease under treatment
with caffeine (0.5 mM or 1 mM) and/or tetrandrine (5 mM).
Fig. 5 shows the concentration of p300 with various concen-
trations of caffeine (0.5 mM or 1 mM) and/or tetrandrine (5 mM) in
RT-2 glioma cells. The expression of p300was signiﬁcantly differentFig. 2. Ratio of mammalian target of rapamycin (mTOR) versus b-actin expressionwith
various concentrations of caffeine (0.5 mM or 1 mM) and/or tetrandrine (5 mM) in RT-2
glioma cells. Expression of mTOR was not signiﬁcantly different in any treatment group
(one-way analysis of variance, p ¼ 0.8981), although mTOR expression tended to
decrease after treatment with caffeine (0.5 mM or 1 mM) and/or tetrandrine (5 mM).
Fig. 5. Concentration of p300 with various concentrations of caffeine (0.5 mM or
1 mM) and/or tetrandrine (5 mM) in RT-2 glioma cells. Expression of p300 was
signiﬁcantly different in all treatment groups (one-way analysis of variance,
p < 0.0001). Compared with the control group (0.486 ± 0.016), p300 expression
increased signiﬁcantly with caffeine (0.5 mM or 1 mM) alone (0.702 ± 0.038, p < 0.001;
0.782 ± 0.040, p < 0.001), tetrandrine (5 mM) alone (0.815 ± 0.046, p < 0.001), and
combined treatment with tetrandrine (5 mM) and caffeine (0.5 mM or 1 mM)
(0.804 ± 0.010, p < 0.001; 0.932 ± 0.015, p < 0.001).
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with the control group. Relative to the control group
(0.486 ± 0.016), the p300 expression increased signiﬁcantly with
caffeine (0.5 mM or 1 mM) alone (0.702 ± 0.038, p < 0.001;
0.782 ± 0.040, p < 0.001), tetrandrine (5 mM) alone (0.815 ± 0.046,
p < 0.001), and combined treatment with tetrandrine (5 mM) and
caffeine (0.5 mM or 1 mM; 0.804 ± 0.010, p < 0.001; 0.932 ± 0.015,
p < 0.001).
4. Discussion
This experimental study showed that caffeine and tetrandrine
can increase glioma cell death additively via increasing p300
expression. However, the expression of mTOR, PTEN, or HDAC1 did
not change signiﬁcantly after treatment with caffeine or tetran-
drine alone or in combination. Previous studies showed that the
PI3K/Akt/mTOR signaling pathway is overexpressed in glioma cells.
On the contrary, blockade of PI3K/Akt/mTOR signaling could induce
caspase-dependent apoptosis and increase autophagy in glioma
cells [3,4]. PTEN is a negative regulatory protein of the mTOR and
PI3K signaling pathway, but is often inactivated in glioma [5,6].
PTEN mutations can result in activated PI3K/Akt survival signaling
associated with resistance to radiotherapy [19]. HDAC1 is a pre-
dominantly nuclear protein with ubiquitous expression. The
expression of HDAC1 is induced upon growth factor activation, and
increased in highly proliferative tissues, embryonic stem cells,
several transformed cell lines, and in the majority of cancers
[20,21]. HAT is also essential for the physiological processes of cell
proliferation, differentiation, and apoptosis [22]. The decreased
expression or mutations of HATs have been associated with several
diseases, such as cardiac hypertrophy, asthma, and several types of
cancer [9,10].
Caffeine has been reported to inhibit some kinase activities,
including various forms of mTOR and PI3K, in tumor cells [17].
Caffeine also reduces glioma cell proliferation through G(0)/G(1)-
phase cell cycle arrest by suppressing retinoblastoma protein
phosphorylation [23]. Furthermore, caffeine can increase PTEN
expression, leading to PI3KeAKT pathway inactivation, and block
osteosarcoma cell proliferation [18]. Caffeine confers radio-
sensitization of PTEN-deﬁcient malignant glioma cells by
enhancing ionizing radiation-induced G1 arrest and negatively
regulating Akt phosphorylation [19]. Caffeine can induce
apoptosis through both the caspase-dependent (caspase-3) and
-independent [poly(ADP-ribose) polymerase cleavage] cell
apoptosis signaling pathways [11e13]. In this study, however,
caffeine did not decrease mTOR expression or increase PTEN
expression signiﬁcantly as reported in previous studies [17,18].
This discrepancy might have been due to differences in cell lines
and/or caffeine concentrations. However, we provided a novel
ﬁnding that caffeine alone or combined with tetrandrine tended
to decrease HDAC1 expression and increased p300 expression
signiﬁcantly in RT2 cells.
Tetrandrine can produce free radical damages, stop progression
of the cell cycle, increase mitogen-activated protein kinase activity,
reverse multidrug resistance, exert antiangiogenesis, and induce
caspase-dependent apoptosis in various cancer cells, including
glioma and/or neuroblastoma cells [11e13,24]. Tetrandrine also
exerts radiosensitization in glioma cells by elimination of radiation-
induced cell cycle perturbation [11e13]. In this study, we showed
that tetrandrine alone or in combination with caffeine can increase
p300 expression signiﬁcantly in RT2 cells, although the expression
of mTOR, PTEN, and HDAC1 was not signiﬁcantly altered.
Histone acetylation has been shown to induce transcriptional
activation. A previous study showed that ethanol could increase
acetylation of H3 at Lysine 9 through modulation of HAT, and thisacetylation can be regulated by the extracellular signal-regulated
kinase (ERK) and c-Jun N-terminal kinase (JNK) signaling path-
ways [25]. Mitogen-activated protein kinases (MAPK; ERK1/2, p38
MAPK, and JNK) can also phosphorylate several types of HATs (e.g.,
CREB-binding protein, activating transcription factor 2, and steroid
receptor coactivator 1) and directly increase their enzymatic ac-
tivities [25,26], or indirectly regulate HAT activity by modifying the
signaling pathways affecting HAT activity [27,28]. We also found
that caffeine and tetrandrine could increase p300 levels, which is
helpful for cancer treatment.5. Conclusion
Combined treatment with caffeine and tetrandrine could in-
crease glioma cell death additively possibly via increasing p300
expression. This combination might be a candidate for human gli-
oma chemotherapy in the future.Acknowledgments
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